Sulaiman, Maela .
HRN: 26-30-39 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/29/2024
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
11/29/2024
12/08/2024
PO
3.5ml
TID
Amoebiasis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes